Physician profile
MD A Karim
NPI 1821329665
$2,145.41
in general payments reported to CMS, 2019-2025
15 companies · $771 in 2025
The $771 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $29.38 · 2021: $234 · 2022: $183 · 2023: $174 · 2024: $521 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,466.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $993.97 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $248.82 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $211.59 | 2021-2025 | |
| Amgen INC. | $125.00 | 2019 | |
| Corcept Therapeutics | $114.14 | 2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $97.08 | 2019 | |
| Glaxosmithkline, LLC. | $75.88 | 2020-2024 | Trelegy Ellipta |
| Pfizer INC. | $66.67 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $52.29 | 2021-2025 | Airsupra, Breztri |
| Exact Sciences Corporation | $49.19 | 2024 | Cologuard Collection Kit |
| Abbott Laboratories | $46.18 | 2022 | |
| Hologic Sales and Service, LLC | $21.88 | 2025 | Aptima |
| Merck Sharp & Dohme LLC | $17.13 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Janssen Pharmaceuticals, INC | $13.82 | 2022 | |
| Eisai INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw MD Karim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.